Danish GDP projected to grow 4.0 percent in 2026 on pharma output
Denmark's economy is projected to grow by 4.0 percent in 2026, driven by an extraordinary increase in foreign pharmaceutical production. Danmarks Nationalbank expects inflation of 1.7 percent alongside balanced domestic capacity.
Pharma production fuels growth without overheating
Danmarks Nationalbank projects Denmark’s gross domestic product will expand by 4.0 percent in 2026, followed by 2.3 percent in 2027 and 2.0 percent in 2028.
The expansion is driven primarily by an extraordinary increase in pharmaceutical manufacturing abroad during the first half of the year.
Because this foreign production requires limited domestic labor and capital, strong economic growth has generated no visible wage or price pressures.
Inflation is projected at 1.7 percent in 2026 before rising to 2.4 percent in 2027 and settling at 2.1 percent in 2028. “The Danish economy has so far defied the global turmoil,” Governor Christian Kettel Thomsen said.
Central bank urges fiscal caution
Despite solid growth, the central bank cautions that domestic spare capacity remains strictly limited amid low unemployment and high employment.
Fiscal policy is set to ease significantly in 2026 and 2027, creating potential capacity risks depending on the import share of defense procurements.
In response, Governor Thomsen advised the government to avoid boosting demand further in the upcoming October Finance Bill and to exercise restraint when deploying the remaining fiscal scope.
Headline vigor hides narrow fiscal room
Strong top-line GDP figures reflect offshore pharmaceutical accounting rather than domestic vitality.
With domestic labor near full capacity, further fiscal loosening risks triggering avoidable wage and price pressures.
The central bank delivers a timely warning against political spending appetites.
Source: Danish economy defies global turmoil
IN: